ArticleTherapeutic advances in neurological disorders2020
Corrigendum to "Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years' Follow-up of DEFINE, CONFIRM, and ENDORSE".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.